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Abstract Rifampicin is an antibiotic which binds to the L
subunit of prokaryotic RNA polymerases and prevents initiation
of transcription. It was found previously that production of heat
shock proteins in Escherichia coli cells after a shift from 30‡C to
43‡C is not completely inhibited by this antibiotic. Here we
demonstrate that while activity of a pL-lacZ fusion (pL is a c
70-
dependent promoter) in E. coli cells is strongly inhibited by
rifampicin, a pgroE-lacZ fusion, whose activity is dependent on
the c32 factor, retains significant residual activity even at
relatively high rifampicin concentrations. Differential sensitivity
to this antibiotic of RNA polymerase holoenzymes containing
either the c70 or the c32 subunit was confirmed in vitro. Since the
effects of an antibiotic that binds to the L subunit can be
modulated by the presence of either the c70 or the c32 subunit in
the holoenzyme, it is tempting to speculate that binding of
various c factors to the core of RNA polymerase results in
different conformations of particular holoenzymes, including
changes in the core enzyme.
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1. Introduction
Escherichia coli RNA polymerase holoenzyme is composed
of the core enzyme (E) and a c factor. The core enzyme
consists of a dimer of K subunits and monomers of L and
LP subunits (for a review see [1]). There are at least seven
alternative c factors in E. coli cells, responsible for recogniz-
ing di¡erent types of promoters [2]. Studies on the structure of
the RNA polymerase reported to date concerned predomi-
nantly the holoenzyme containing the most abundant c fac-
tor, c70, responsible for recognition of most E. coli genes
(such a holoenzyme is abbreviated Ec70) [1]. However, it is
not known whether binding of di¡erent c subunits to the core
enzyme is a simple exchange of a factor without any e¡ect on
the core structure, or conformation of the core may vary
considerably upon binding of di¡erent c subunits. In fact,
in simpli¢ed models, RNA polymerase holoenzyme molecules
are usually presented as an unchanged core bound to various
c factors of di¡erent sizes [3].
Rifampicin is an antibiotic which binds to the L subunit of
RNA polymerase [4,5], either as the free protein or in its
complex with DNA (for a review see [6]). In the presence of
this antibiotic, RNA polymerase is able to initiate RNA
chains but is unable to make products that are longer than
three residues, and transcription elongation is not a¡ected by
rifampicin [6,7]. It is also worth mentioning that studies on
the mechanism of rifampicin-mediated inhibition of transcrip-
tion were performed predominantly using Ec70. Since rifam-
picin binds to the L subunit, it might be assumed that hol-
oenzymes bearing other c factors should be similarly a¡ected
by this antibiotic.
Recent studies led to the unexpected observation that con-
siderable synthesis of at least some heat shock proteins occurs
in the presence of rifampicin after shifting an E. coli culture
from 30‡C to 43‡C [8]. Transcription of most heat shock genes
is dependent on the c32 factor [2]. Therefore, in this work we
investigated the sensitivity to rifampicin of RNA polymerase
holoenzymes containing either the c70 or the c32 subunit (i.e.
Ec70 or Ec32 respectively).
2. Materials and methods
2.1. Bacterial strains and fusions
Escherichia coli strain WAM106 (F3, araD139, v(argF-lac)U169,
v(his-gnd), thi, rpsL150, gltSo, £bB5301, relA1, deoC1, rbsR) has al-
ready been described [9]. Single copy fusions bearing the lacZ gene
under the control of the c70-dependent pL promoter (kindly provided
by D. Court, see also [8]) or c32-dependent pgroE promoter [10] were
used.
2.2. Measurement of L-galactosidase activity
Activity of L-galactosidase was measured according to Miller [11].
2.3. Measurement of total RNA synthesis
Total RNA synthesis was measured as described previously [12].
Brie£y, [3H]uridine was added to the bacterial cultures to a ¢nal
concentration of 2 WCi/5 Wg/ml. Samples were withdrawn at indicated
times and transferred onto paper ¢lters. The ¢lters were placed im-
mediately in 10% ice-cold trichloroacetic acid (TCA) for 10 min and
transferred to 5% TCA for 10 min. Then the samples were washed
twice with 96% ethanol, and dried at room temperature. The radio-
activity of the samples was estimated in a scintillation counter.
2.4. In vitro transcription
Run o¡ in vitro transcription assays were performed as described
previously [13,14]. The bands on autoradiograms were quantitated by
densitometry. E. coli RNA polymerase core enzyme and holoenzyme
saturated with the c70 subunit were purchased from Epicentre Tech-
nologies. The c32 factor was puri¢ed as described previously [15].
Plasmid pOF39 [16] cleaved with SacII was used as a template for
in vitro transcription assays.
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3. Results
3.1. Sensitivity of pL-lacZ and pgroE -lacZ fusions to rifampicin
in E. coli cells
We studied activities of pL-lacZ and pgroE-lacZ fusions in E.
coli cells. The pL promoter of bacteriophage V is a typical c70-
dependent promoter. The E. coli groE operon is under the
control of both c70- and c32-dependent promoters, however
the fusion used in this study contains exclusively the pgroE
promoter recognized by Ec32 (see [10] for details). Transcrip-
tion initiation from c32-dependent promoters is e¡ective upon
shifting the bacterial cultures to a high temperature (for ex-
ample 43‡C). In order to keep the same conditions for meas-
uring activities of both fusions, bacteria harboring either the
c70-dependent pL-lacZ or the c32-dependent pgroE-lacZ fusion
were cultivated at 30‡C and then shifted to 43‡C. The pL
promoter activity was repressed at 30‡C by a thermosensitive
product of the cI857 gene present on a cryptic prophage.
Therefore, upon temperature shift, activities of both pro-
moters were stimulated. We found that addition of rifampicin
to a ¢nal concentration of 25 Wg/ml resulted in almost total
inhibition of transcription from the c70-dependent pL pro-
moter, whereas the c32-dependent pgroE promoter retained
considerable activity under these conditions (Fig. 1).
In order to compare sensitivities of both fusions to rifam-
picin in more detail, we measured their activities at di¡erent
concentrations of this antibiotic. We found that transcription
from the c70-dependent pL promoter is inhibited at signi¢-
cantly lower rifampicin concentrations than transcription
from the c32-dependent pgroE promoter (Fig. 2).
3.2. Total in vivo RNA synthesis in the presence of rifampicin
In experiments presented in Figs. 1 and 2, rifampicin was
added to bacterial cultures at the time of the temperature
shift. As rifampicin must enter bacteria through the cell enve-
lope to mediate inhibition of transcription, this process may
take some time before e¡ects caused by this antibiotic can be
observed. Therefore, in control experiments we measured total
RNA synthesis at di¡erent times after rifampicin addition
under the same conditions as employed for experiments de-
picted in Figs. 1 and 2. As shown in Fig. 3, signi¢cant rifam-
picin-mediated inhibition of RNA synthesis was observed as
soon as a few minutes after addition of the antibiotic to the
bacterial culture. Since in this type of experiments we moni-
tored mainly synthesis of stable RNAs, these results also in-
dicate e⁄cient inhibition by rifampicin of c70-dependent pro-
moters for synthesis of rRNA and tRNA.
3.3. Inhibition of transcription from c70- and c32-dependent
promoters by rifampicin in vitro
The in vivo e¡ects of rifampicin on activities of the fusions
bearing the lacZ reporter gene under control of c70- or c32-
dependent promoter (Figs. 1 and 2) may be direct, but one
could also imagine an indirect inhibition of transcription from
both promoters. Therefore, we aimed to investigate the sensi-
tivity to rifampicin of transcription by Ec70 and by Ec32 in
vitro. The wild-type groE operon of E. coli, present also on
plasmid pOF39 [16], is under the control of both c70- and c32-
dependent promoters. Thus, transcription from both pro-
moters may be investigated using the same template ^ plasmid
pOF39 digested with SacII [13]. The results presented in Fig. 4
demonstrate that in vitro Ec70-mediated transcription is con-
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Fig. 1. Activities of c70-dependent pL-lacZ (A) and c32-dependent
pgroE-lacZ (B) fusions in E. coli cells non-treated (circles) and
treated with rifampicin (squares) at ¢nal concentration of 25 Wg/ml.
Both addition of rifampicin and temperature shift (from 30‡C to
43‡C) were performed at time = 0. L-Galactosidase activities are
shown in Miller units (MU).
Fig. 2. Activities of c70-dependent pL-lacZ (circles) and c32-depend-
ent pgroE-lacZ (squares) fusions in E. coli cells treated with indicated
concentrations of rifampicin. Both addition of rifampicin and tem-
perature shift (from 30‡C to 43‡C) were performed at time = 0, and
activities of L-galactosidase were measured 60 min later. Activities
obtained with cultures non-treated with rifampicin were assumed to
be 100% and other values re£ect these values. The results are the
average of at least two independent measurements.
Fig. 3. Synthesis of total RNA (measured by incorporation of
[3H]uridine to TCA-precipitable material) in E. coli cells non-treated
(circles) and treated with rifampicin (squares) at a ¢nal concentra-
tion of 25 Wg/ml. Both addition of rifampicin and temperature shift
(from 30‡C to 43‡C) were performed at time = 0.
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siderably more sensitive to rifampicin than Ec32-mediated
transcription. At 5 ng/ml, rifampicin had no signi¢cant e¡ect
on transcription from both c70- and c32-dependent promoters.
However, densitometric analysis of the bands on autoradio-
grams presented in Fig. 4 revealed that at 10 ng/ml of rifam-
picin, the e⁄ciency of transcription from the c70-dependent
promoter was only about 10% of that observed without this
antibiotic, whereas the impairment of e⁄ciency of transcrip-
tion from the c32-dependent promoter was negligible. Signi¢-
cant transcription from the c32-dependent promoter (about
20% of that found in the sample without antibiotic) was ob-
served even at 50 ng/ml of rifampicin. Nevertheless, at very
high rifampicin concentrations transcription from both pro-
moters was inhibited, similarly to the results obtained in vivo
(compare Figs. 2 and 4).
4. Discussion
It was found previously that signi¢cant synthesis of at least
some heat shock proteins proceeds in E. coli cells upon a shift
from 30‡C to 43‡C in the presence of rifampicin [8]. Here we
demonstrate that, contrary to c70-dependent promoters (the
pL promoter, promoters for stable RNA synthesis, c70-de-
pendent pgroE promoter), transcription from the c32-dependent
pgroE promoter proceeds relatively e⁄ciently even at high con-
centrations of rifampicin, both in vivo and in vitro.
Rifampicin binds to the L subunit of RNA polymerase [4,5]
and inhibits transcription at the initiation stage (production of
RNA chains longer than three nucleotides is prevented) with-
out signi¢cant e¡ects on elongation [6,7]. Therefore, one
might assume that the e¡ect of rifampicin on transcription
should be independent of the kind of c factor bound to the
core of RNA polymerase. However, the results presented in
this report indicate that Ec70 may be signi¢cantly more sensi-
tive to rifampicin than Ec32. One possible hypothesis to ex-
plain this phenomenon is that RNA polymerase holoenzymes
bearing di¡erent c factors di¡er considerably in their struc-
ture (including the structure of the core enzyme or at least the
L subunit). Thus, either the e⁄ciency of binding of rifampicin
to the L subunit or its e¡ects on transcription may be di¡erent
for various RNA polymerase holoenzymes. In generally ac-
cepted models of the structure of RNA polymerase, it is as-
sumed that the structure of the core enzyme is not signi¢-
cantly changed when bound to di¡erent c subunits [3]. This
might not necessarily be true if the above hypothesis is cor-
rect. It is also possible that access to the rifampicin binding
site is more occluded when c32 is bound to the core enzyme
than when c70 is bound. However, since c32 is a considerably
smaller polypeptide than c70, we assume that the former hy-
pothesis is more probable.
An alternative, though in our opinion less likely, explana-
tion for the results presented in this report is that di¡erences
in the structure of promoters recognized by various RNA
polymerase holoenzymes may somehow in£uence the e⁄-
ciency of rifampicin-mediated inhibition of transcription ini-
tiation.
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Fig. 4. In vitro transcription from the c70-dependent pgroE promoter
(A) and the c32-dependent pgroE promoter (B) in the presence of rif-
ampicin. Rifampicin concentrations (in ng/ml) are provided above
the lanes. 1 U of Ec70 (Epicentre Technologies) per reaction (A),
and 1 U of the core enzyme (Epicentre Technologies) mixed with
0.16 Wg of puri¢ed c32 factor per reaction (B) were used. 0.5 Wg of
plasmid pOF39 digested with SacII was used as a template in the in
vitro run o¡ reactions.
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